I suspect those inclined to the current approach will diagnose more pwME with fibromyalgia; the new NICE chronic pain draft gives them carte blanche to take a thoroughly BPS approach. Alternatively, they could add a diagnosis of a "somatoform disorder", adopt Fink's "bodily distress syndrome", or simply present CBT and graded exercise as ancillary, supportive therapies.
Speaking of the draft chronic pain guidelines, I've heard that at my local pain management clinic, all patients with a diagnosis such as fibromyalgia and CRPS, where pain isn't secondary to a known/objectively demonstrable process, as well as patients being treated for low back pain and some neuropathic pain conditions are being chart-reviewed with a view to de-prescribing, particularly opioids and gabapentinoids. A new pain management course is being held over Zoom, a new ACT therapist has been hired, some nerve-block procedures have been suspended, and all IV lidocaine infusions have been cancelled. Patients querying this have been told the changes are in accordance with the NICE guidelines for chronic pain, even though it's only in draft and many objections to that draft have been raised. If such changes occur in other trusts, they may affect many pwME dependent on analgesia for whom myalgia is a prominent symptom.
I'm not concerned about a judicial review - it would be difficult to argue that a decision made by a committee whose vice chair is a former president of both RSM and BMA could not have been made by any reasonable person - but I am concerned that there may be a media campaign in response to a decision adverse to the BPS position intended to discredit the result as an artefact of patient pressure; we are already so very stigmatised.
On an unrelated note, does anyone know the situation in regard to Scotland? I know NICE guidelines aren't directly applicable; is there a prospect of
SIGN adopting the new NICE guideline in whole or in part?